Click to Skip Ad
Closing in...
NVX-CoV2373 News

We have more good news about a coronavirus vaccine

A coronavirus vaccine candidate from Novavax completed its Phase 1 trial with promising results. The NVX-CoV2373 drug induced neutralizing antibodies in all the volunteers who were given shots. A T cell response was >>